(Q52548383)

3 May 2018

title

Clinical significance of P16INK4A and retinoblastoma proteins in non-small-cell lung carcinoma. (English)

1 reference

3 May 2018

1 reference

Hale Akin

1

1 reference

3 May 2018

Dilek Yilmazbayhan

2

1 reference

3 May 2018

Zeki Kiliçaslan

3

1 reference

3 May 2018

Sükrü Dilege

4

1 reference

3 May 2018

Oner Doğan

5

1 reference

3 May 2018

Alper Toker

6

1 reference

3 May 2018

Göksel Kalayci

7

1 reference

3 May 2018

publication date

1 December 2002

1 reference

3 May 2018

published in

Lung Cancer

1 reference

3 May 2018

volume

38

1 reference

3 May 2018

issue

3

1 reference

3 May 2018

page(s)

253-260

1 reference

3 May 2018

The effect of surgical treatment on survival from early lung cancer. Implications for screening

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

Prognostic markers in resectable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

Molecular pathogenesis of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

Tumor suppressor genes and the practice of surgical pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

How many tumor suppressor genes are involved in human lung carcinogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

Malignant melanoma arising from nevi, p53, p16, and Bcl-2: expression in benign versus malignant components

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

Expression of p16 and lack of pRB in primary small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

Prognostic value of the immunohistochemical detection of p16INK4 expression in nonsmall cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

Loss of p16 and/or pRb protein expression in NSCLC. An immunohistochemical and prognostic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900301-X

7 January 2021

10.1016/S0169-5002(02)00301-X

Identifiers

DOI

1 reference

3 May 2018

PubMed ID

12445746

1 reference

3 May 2018